Back to Search
Start Over
[Molnupiravir or nirmatrelvir-ritonavir reduce the likelihood of hospitalization and mortality in immunocompromised patients with Covid-19.]
- Source :
-
Recenti progressi in medicina [Recenti Prog Med] 2024 Sep; Vol. 115 (9), pp. 399. - Publication Year :
- 2024
- Subjects :
- Humans
Cytidine analogs & derivatives
Cytidine therapeutic use
Hydroxylamines therapeutic use
Leucine analogs & derivatives
Leucine therapeutic use
Proline analogs & derivatives
Proline therapeutic use
Sulfonamides administration & dosage
Sulfonamides therapeutic use
COVID-19 prevention & control
Lactams
Nitriles
COVID-19 Drug Treatment
Ritonavir therapeutic use
Ritonavir administration & dosage
Hospitalization statistics & numerical data
Immunocompromised Host
Antiviral Agents therapeutic use
Antiviral Agents administration & dosage
Drug Combinations
Subjects
Details
- Language :
- Italian
- ISSN :
- 2038-1840
- Volume :
- 115
- Issue :
- 9
- Database :
- MEDLINE
- Journal :
- Recenti progressi in medicina
- Publication Type :
- Academic Journal
- Accession number :
- 39269352
- Full Text :
- https://doi.org/10.1701/4334.43179